首页 | 本学科首页   官方微博 | 高级检索  
     

成都地区2型糖尿病患者糖耐量正常一级亲属代谢紊乱的临床研究
引用本文:刘宋芳,龚媛,刘圆圆,宋洁,田浩明,陈涛,冉兴无,喻红玲,张祥迅,龙洋,任艳. 成都地区2型糖尿病患者糖耐量正常一级亲属代谢紊乱的临床研究[J]. 华西医学, 2011, 0(2): 177-180
作者姓名:刘宋芳  龚媛  刘圆圆  宋洁  田浩明  陈涛  冉兴无  喻红玲  张祥迅  龙洋  任艳
作者单位:四川大学华西医院内分泌代谢科;四川大学华西医院内分泌及代谢病实验室
摘    要:目的调查成都地区2型糖尿病患者糖耐量正常一级亲属的代谢状态及与胰岛素抵抗、胰岛β细胞功能的相关性。方法 2007年7 9月共纳入糖耐量正常的一级亲属312例(NGT-FDR组),无家族史的正常对照1 348例(NGT-C组)。测量两组血压、体重、腰围;检测口服葡萄糖耐量试验(OGTT)中0、0.5、2h血糖、胰岛素水平;测定空腹血脂;计算体重指数、HOMA-胰岛素抵抗指数(HOMA-IR)、胰岛β细胞功能指数(HOMA-β),β细胞早相分泌功能指数(△I30/△G30),并比较两组间上述指标的差异和代谢综合征(MS)及其各组分的发病情况。结果①NGT-FDR组MS发生率高于NGT-C组,发生MS的风险是后者的1.737倍。NGT-FDR组高甘油三酯血症(hypertriglyceridemia,HTG)、空腹血糖偏高(5.6~6.0mmol/L)的发生率高于NGT-C组,合并4种及以上代谢异常的几率亦高于NGT-C组(P〈0.05);②年龄〈40岁的NGT-FDR中心性肥胖、HTG、空腹血糖偏高和MS均高于同年龄对照;男性NGT-FDR空腹血糖偏高和MS发病率高于男性对照(P〈0.05);③腰围、收缩压(SBP)、空腹血糖(FBG)、甘油三酯(TG)及糖尿病家族史同HOMA-IR呈正相关。腰围、SBP、TG及糖尿病家族史同HOMA-β呈正相关,FBG则同HOMA-β呈负相关。结论 2型糖尿病糖耐量正常一级亲属比无家族史的对照表现出更多的代谢异常,尤其是在年龄〈40岁及男性中。各种代谢异常可加重胰岛素抵抗,影响胰岛基础分泌功能。故有必要对糖耐量正常的一级亲属进行各项代谢指标的监测和早期预防性干预。

关 键 词:2型糖尿病  代谢异常  糖耐量正常一级亲属

Clinical Study on Metabolic Status of Normal Glucose-Tolerant First-degree Relatives of Type-2 Diabetic Patients in Chengdu Area of China
LIU Song-fang,GONG Yuan,LIU Yuan-yuan,SONG Jie,TIAN Hao-ming,CHEN Tao,RAN Xing-wu,YU Hong-ling,ZHANG Xiang-xun,LONG Yang,REN Yan. Clinical Study on Metabolic Status of Normal Glucose-Tolerant First-degree Relatives of Type-2 Diabetic Patients in Chengdu Area of China[J]. West China Medical Journal, 2011, 0(2): 177-180
Authors:LIU Song-fang  GONG Yuan  LIU Yuan-yuan  SONG Jie  TIAN Hao-ming  CHEN Tao  RAN Xing-wu  YU Hong-ling  ZHANG Xiang-xun  LONG Yang  REN Yan
Affiliation:1.1.Department of Endocrinology and Metabolism;2.Laboratory of Endocrinology and Metabolism,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,P.R.China
Abstract:Objective To investigate the metabolic status of the normal glucose-tolerant first-degree relatives(NGT-FDR) of type-2 diabetic patients and its relationship with insulin resistance(IR) and β-cell function in Chengdu area.Methods From July to September 2007,a total of 312 NGT-FDR of type-2 diabetic patients and 1 348 normal glucose tolerant controls without positive family history of diabetes(NGT-C) were enrolled in this study.Blood pressure,weight,waists,plasma glucose at hour 0,1/2 and 2 in oral glucose tolerance test(OGTT),insulin levels and fasting blood lipids were measured.Body mass index(BMI),HOMA-IR,HOMA-β and the early insulin secreting index(△I30/△G30) were calculated.Then,we compared the above-mentioned data and the incidence of metabolic syndrome(MS) between the two groups.Results ①The incidence of MS,hypertriglyceridemia(HTG),higher fasting blood glucose(FBG)(5.6-6.0 mmol/L) in the NGT-FDR group were all significantly higher than those in the NGT-C group.The risk of developing MS in the NGT-FDR group was 1.737 times as high as that in the NGT-C group.Furthermore,the incidence of 4 or more than 4 co-existent metabolic disorders in the NGT-FDR group was also significantly higher than that in the NGT-C group(P〈0.05);②For subjects less than 40 years old,the incidence of central obesity,HTG,higher FBG and MS in the NGT-FDR group were all higher than those in the NGT-C group.In male subjects,the rates of higher FBG and MS were all significantly higher in the NGT-FDR group than those in the NGT-C group.(P〈0.05);③Waists,FBG,systolic blood pressure(SBP),triglycerides(TG) and diabetic family history were positively correlated with HOMA-IR.Waists,SBP,TG and diabetic family history were positively correlated with HOMA-β.Conclusion NGT-FDR present significantly increased metabolic disorders than NGT controls,especially in the less than 40-year-old and the male subjects.The metabolic disorders can aggravate insulin resistance and influence islet β-cell secretion function,so it is necessary to monitor the metabolic status of the NGT-FDR of type-2 diabetic patients and provide early preventive interventions.
Keywords:Type -2 diabetes  Metabolic disorder  Normal glucose tolerant first degree relatives
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号